Molecular pathology assists the diagnosis of lymphoepithelial sialadenitis, Sjögren's syndrome and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.
暂无分享,去创建一个
Qiulu Zhang | Cui-ling Liu | Z. Qin | J. Bai | Binbin Li | Jing Yan | Y. Chi | Zhiming Qin
[1] S. Swerdlow,et al. IRTA1 positivity helps identify a MALT‐lymphoma‐like subset of primary cutaneous marginal zone lymphomas, largely but not exclusively defined by IgM expression , 2021, Journal of cutaneous pathology.
[2] Jun Zhu,et al. Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version) , 2021, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[3] A. Vissink,et al. Gene expression profiling of epithelium-associated FcRL4+ B cells in primary Sjögren’s syndrome reveals a pathogenic signature , 2020, Journal of autoimmunity.
[4] A. Salar,et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] Toru Nakamura,et al. Primary thymic MALT lymphoma in a patient with Sjögren’s syndrome and multiple lung cysts: a case report , 2019, Surgical Case Reports.
[6] K. Stamatopoulos,et al. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS , 2019, Leukemia.
[7] M. Koutsilieris,et al. TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients , 2018, Journal of immunology research.
[8] E. Mardis,et al. Next-Generation Sequencing Technologies. , 2018, Cold Spring Harbor perspectives in medicine.
[9] J. Cook,et al. IRTA1 and MNDA Expression in Marginal Zone Lymphoma: Utility in Differential Diagnosis and Implications for Classification , 2018, American Journal of Clinical Pathology.
[10] Dan Yu,et al. Evaluation of the diagnostic value of immunoglobulin clonal gene rearrangements in patients with parotid gland MALT lymphoma using BIOMED-2 protocol. , 2018, Oral surgery, oral medicine, oral pathology and oral radiology.
[11] A. Vissink,et al. FcRL4+ B-cells in salivary glands of primary Sjögren's syndrome patients. , 2017, Journal of autoimmunity.
[12] N. Nikitakis,et al. MALT Lymphoma of Minor Salivary Glands in a Sjögren’s Syndrome Patient: a Case Report and Review of Literature , 2017, Journal of oral & maxillofacial research.
[13] L. Criswell,et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome , 2016, Annals of the rheumatic diseases.
[14] B. Treanor,et al. Involvement of the HCK and FGR src-Family Kinases in FCRL4-Mediated Immune Regulation , 2015, The Journal of Immunology.
[15] E. Sakhinia,et al. Probing PARP1-inhibitor complexes for the development of novel inhibitors. , 2014, Cellular and molecular biology.
[16] S. Pileri,et al. IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas , 2012, Histopathology.
[17] E. Schuuring,et al. EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations , 2012, Leukemia.
[18] G. Gaidano,et al. Clinical and molecular features of mucosa‐associated lymphoid tissue (MALT) lymphomas of salivary glands , 2009, Head & neck.
[19] H. Noels,et al. The pathogenesis of MALT lymphomas: where do we stand? , 2007, Leukemia.
[20] A. Ebens,et al. Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. , 2006, International immunology.
[21] M Hummel,et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.
[22] L. Pasqualucci,et al. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). , 2003, Blood.
[23] R. Jonsson,et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.
[24] L. Weiss,et al. Assessment of clonality in lymphoid proliferations. , 1993, The American journal of pathology.
[25] H. Stein,et al. T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution. , 2005, Haematologica.
[26] N. Harris. Lymphoid proliferations of the salivary glands. , 1999, American journal of clinical pathology.